The assessment of beta-adrenoceptor blocking drugs in man.
D000318:Adrenergic beta-Agonists; D000319:Adrenergic beta-Antagonists / Q000097:blood / Q000494:pharmacology*; D000818:Animals; D004305:Dose-Response Relationship, Drug; D006321:Heart / Q000187:drug effects; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D066298:In Vitro Techniques; D007263:Infusions, Parenteral; D007275:Injections, Intravenous; D007545:Isoproterenol / Q000008:administration & dosage / Q000037:antagonists & inhibitors; D008566:Membranes / Q000187:drug effects; D005996:Nitroglycerin / Q000037:antagonists & inhibitors; D009928:Organ Specificity; D005082:Physical Exertion
D000318:Adrenergic beta-Agonists; D000319:Adrenergic beta-Antagonists; D005996:Nitroglycerin; D007545:Isoproterenol